Back
Knight Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
GUD.TO
Knight Therapeutics, Inc.
Last Price:
$6.00
Seasonality Move:
-3.59%
7 Day Trial
ALL ACCESS PASS
$
7
Knight Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Knight Therapeutics, Inc. has on average historically risen by 7.2% based on the past 15 years of stock performance.
-
Knight Therapeutics, Inc. has risen higher in 9 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Knight Therapeutics, Inc. Stock Undervalued?The current Knight Therapeutics, Inc. [GUD.TO] share price is $6.00. The Score for GUD.TO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
GUD.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Knight Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Knight Therapeutics, Inc. has on average historically risen by 7.2% based on the past 15 years of stock performance.
Knight Therapeutics, Inc. Stock Rating
Sell
37
Knight Therapeutics, Inc. (GUD.TO)
is a Sell
Is Knight Therapeutics, Inc. overpriced?
-
Knight Therapeutics, Inc. has risen higher in 9 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Knight Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
TSX
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
gud-knight.com
52-Week Data
52-Week High:
6.55
52-Week Low:
5.11
Prediction Charts
Market Cap:
595.7M
Price in USD:
6.00
Volume:
42.3K
Beta:
0.28
Technical Analysis
SMA50:
5.98
SMA100:
6.11
SMA200:
6.02
52-Wk Change:
16.28%
Stock Predictions
-
Is Knight Therapeutics, Inc. stock public?Yes, Knight Therapeutics, Inc. is a publicly traded company.
-
What is the Knight Therapeutics, Inc. stock quote today?The Knight Therapeutics, Inc. stock price is 6.00 USD today.
-
How to buy Knight Therapeutics, Inc. stock online?You can buy Knight Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 6.07 | 6.02 | 6.07 | 6.01 |
| Dec-3 | 6.06 | 6.04 | 6.06 | 6.01 |
| Dec-4 | 6.04 | 6.05 | 6.09 | 6.04 |
| Dec-5 | 6.06 | 6.05 | 6.17 | 6.00 |
| Dec-8 | 6.02 | 5.94 | 6.02 | 5.93 |
| Dec-9 | 5.94 | 5.92 | 6.01 | 5.92 |
| Dec-10 | 5.90 | 6.03 | 6.03 | 5.88 |
| Dec-11 | 6.00 | 6.08 | 6.10 | 6.00 |
| Dec-12 | 6.01 | 6.07 | 6.07 | 6.00 |
| Dec-15 | 6.01 | 6.01 | 6.12 | 6.01 |
| Dec-16 | 5.99 | 6.08 | 6.08 | 5.99 |
| Dec-17 | 6.06 | 6.03 | 6.06 | 6.00 |
| Dec-18 | 6.04 | 6.04 | 6.06 | 6.00 |
| Dec-19 | 6.05 | 6.00 | 6.05 | 5.97 |
Knight Therapeutics, Inc. Earnings
Knight Therapeutics, Inc. Earnings Report: Per Share Knight Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Knight Therapeutics, Inc. Forecast Revenue Growth
Knight Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Knight Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.06 per share.
* Knight Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.